| Product Code: ETC10762601 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Suriname pediatric vaccine import market saw significant growth in 2024, with Brazil, USA, India, Netherlands, and France emerging as the top exporting countries. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), increased from high to very high in 2024. This indicates a more concentrated market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 11.09%, with a remarkable growth rate of 109.35% from 2023 to 2024, reflecting a surge in demand for pediatric vaccines in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Pediatric Vaccine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Pediatric Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Pediatric Vaccine Market - Industry Life Cycle |
3.4 Suriname Pediatric Vaccine Market - Porter's Five Forces |
3.5 Suriname Pediatric Vaccine Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F |
3.6 Suriname Pediatric Vaccine Market Revenues & Volume Share, By Disease Type, 2022 & 2032F |
3.7 Suriname Pediatric Vaccine Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 Suriname Pediatric Vaccine Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Suriname Pediatric Vaccine Market Revenues & Volume Share, By Age Group, 2022 & 2032F |
4 Suriname Pediatric Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Pediatric Vaccine Market Trends |
6 Suriname Pediatric Vaccine Market, By Types |
6.1 Suriname Pediatric Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Pediatric Vaccine Market Revenues & Volume, By Vaccine Type, 2022 - 2032F |
6.1.3 Suriname Pediatric Vaccine Market Revenues & Volume, By Live Attenuated, 2022 - 2032F |
6.1.4 Suriname Pediatric Vaccine Market Revenues & Volume, By Inactivated, 2022 - 2032F |
6.1.5 Suriname Pediatric Vaccine Market Revenues & Volume, By Subunit, 2022 - 2032F |
6.1.6 Suriname Pediatric Vaccine Market Revenues & Volume, By Toxoid, 2022 - 2032F |
6.1.7 Suriname Pediatric Vaccine Market Revenues & Volume, By Conjugate, 2022 - 2032F |
6.2 Suriname Pediatric Vaccine Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Pediatric Vaccine Market Revenues & Volume, By Respiratory Infections, 2022 - 2032F |
6.2.3 Suriname Pediatric Vaccine Market Revenues & Volume, By Gastrointestinal Diseases, 2022 - 2032F |
6.2.4 Suriname Pediatric Vaccine Market Revenues & Volume, By Neurological Diseases, 2022 - 2032F |
6.2.5 Suriname Pediatric Vaccine Market Revenues & Volume, By Bloodborne Diseases, 2022 - 2032F |
6.2.6 Suriname Pediatric Vaccine Market Revenues & Volume, By Bacterial Infections, 2022 - 2032F |
6.3 Suriname Pediatric Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Suriname Pediatric Vaccine Market Revenues & Volume, By mRNA, 2022 - 2032F |
6.3.3 Suriname Pediatric Vaccine Market Revenues & Volume, By Recombinant, 2022 - 2032F |
6.3.4 Suriname Pediatric Vaccine Market Revenues & Volume, By DNA-Based, 2022 - 2032F |
6.3.5 Suriname Pediatric Vaccine Market Revenues & Volume, By Viral Vector, 2022 - 2032F |
6.3.6 Suriname Pediatric Vaccine Market Revenues & Volume, By Protein Subunit, 2022 - 2032F |
6.4 Suriname Pediatric Vaccine Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Suriname Pediatric Vaccine Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Suriname Pediatric Vaccine Market Revenues & Volume, By Pediatric Clinics, 2022 - 2032F |
6.4.4 Suriname Pediatric Vaccine Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.5 Suriname Pediatric Vaccine Market Revenues & Volume, By Government Programs, 2022 - 2032F |
6.4.6 Suriname Pediatric Vaccine Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.5 Suriname Pediatric Vaccine Market, By Age Group |
6.5.1 Overview and Analysis |
6.5.2 Suriname Pediatric Vaccine Market Revenues & Volume, By Infants, 2022 - 2032F |
6.5.3 Suriname Pediatric Vaccine Market Revenues & Volume, By Children, 2022 - 2032F |
6.5.4 Suriname Pediatric Vaccine Market Revenues & Volume, By Adolescents, 2022 - 2032F |
6.5.5 Suriname Pediatric Vaccine Market Revenues & Volume, By Neonates, 2022 - 2032F |
6.5.6 Suriname Pediatric Vaccine Market Revenues & Volume, By Pre-Teens, 2022 - 2032F |
7 Suriname Pediatric Vaccine Market Import-Export Trade Statistics |
7.1 Suriname Pediatric Vaccine Market Export to Major Countries |
7.2 Suriname Pediatric Vaccine Market Imports from Major Countries |
8 Suriname Pediatric Vaccine Market Key Performance Indicators |
9 Suriname Pediatric Vaccine Market - Opportunity Assessment |
9.1 Suriname Pediatric Vaccine Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F |
9.2 Suriname Pediatric Vaccine Market Opportunity Assessment, By Disease Type, 2022 & 2032F |
9.3 Suriname Pediatric Vaccine Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.4 Suriname Pediatric Vaccine Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Suriname Pediatric Vaccine Market Opportunity Assessment, By Age Group, 2022 & 2032F |
10 Suriname Pediatric Vaccine Market - Competitive Landscape |
10.1 Suriname Pediatric Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Suriname Pediatric Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here